Location History:
- Pune, IN (2000 - 2002)
- Hamden, CT (US) (2008)
Company Filing History:
2 out of 192 
1 out of 25 
1 out of 832,891 Years Active: 2000-2008
Title: Anupama Shirali: Innovator in Anti-Cancer Compounds
Introduction
Anupama Shirali is a distinguished inventor based in Hamden, CT (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-cancer compounds. With a total of 3 patents to her name, her work is paving the way for innovative treatments in oncology.
Latest Patents
One of her latest patents focuses on chromene-containing compounds with anti-tubulin and vascular targeting activity. These chrome compounds exhibit impressive cytotoxicity and a remarkable ability to inhibit tubulin polymerization. Such compounds, along with their related derivatives, are excellent clinical candidates for the treatment of cancer in humans. Additionally, certain ligands, as pro-drugs, may prove to be tumor-selective vascular targeting chemotherapeutic agents. They may also have vascular targeting activity that results in the selective prevention and/or destruction of nonmalignant proliferating vasculature.
Career Highlights
Anupama has worked at Baylor University, where she has contributed to various research projects. Her innovative approach and dedication to her work have established her as a prominent figure in her field.
Collaborations
Throughout her career, Anupama has collaborated with notable individuals such as Kevin G Pinney and George R Pettit. These collaborations have further enhanced her research and development efforts.
Conclusion
Anupama Shirali's contributions to the field of anti-cancer research are noteworthy. Her innovative patents and collaborations highlight her commitment to advancing medical science. Her work continues to inspire future innovations in cancer treatment.